SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotech Jim who wrote (10734)4/28/2016 10:26:36 AM
From: Biotech Jim  Read Replies (1) of 12215
 
Third tranche of CARA obtained this morning, under $6. Now time to rise.

As to the post op pain trial put on clinical hold, there were 4 pts showing mild hypernatremia (>150 mmol/L) of which 2 were protocol violations. For future dosings, keep in mind the dosing interval vs earlier work. The 4 hypernatremia patients displayed highs of Na+ at 154, 151, 151 and 150.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext